- Home
- / Novartis France
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Novartis France financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€2.3 B
FY, 2021
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 2.2B | 2.2B | 2.3B |
| Cost of goods sold | 1.5B | 1.5B | 1.4B |
| Gross profit | 716.3M | 704.0M | 844.1M |
| Gross profit margin, % | 32.4% | 32.6% | 36.9% |
| General and administrative expense | 259.3M | 256.7M | 258.2M |
| Operating expense total | 574.9M | 619.5M | 719.4M |
| Depreciation and amortization | 15.2M | 23.0M | 23.3M |
| EBIT | 126.1M | 116.9M | 124.7M |
| EBIT margin, % | 5.7% | 5.4% | 5.4% |
| Interest income | 1.5K | 375.5K | |
| Interest expense | 10.9M | 10.0M | 10.5M |
| Pre tax profit | 115.2M | 107.0M | 114.4M |
| Income tax expense | 37.0M | 26.6M | 27.7M |
| Net Income | 84.7M | (19.6M) | 47.0M |